For most people, that means a combination of lifestyle changes, nutritional support, and possibly even medical treatments that target the root cause
Treatment begins at 2.5 mg weekly for four weeks, then increases to 5 mg
Collection: Peptide Pens Pre-filled peptide pens and ready-to-use applicators
The patient will be responsible for administering medication once a week at home
Semaglutide's Clinical Development and Approval Timeline Semaglutide was originally developed as a diabetes treatment and approved by the FDA in 2017 under the brand name Ozempic
Consequently, a phase 3 trial on ambroxol has been planned and is due to start recruitment in the near future (NCT05778617), a phase 2 trial in GBA-associated PD is ongoing (NCT05287503) [124], and another phase 2 trial on PD dementia is expected to finish in December 2025 (NCT02914366) [125]